The Current Ratio as of November 2024 (TTM) for ProPhase Labs, Inc. (PRPH) is 1.47

According to ProPhase Labs, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 1.47. This represents a change of -18.39% compared to the average of 1.80 of the last 4 quarters.

ProPhase Labs, Inc. (PRPH) Historical Current Ratio (quarterly & annually)

How has PRPH Current Ratio performed in the past?

The mean historical Current Ratio of ProPhase Labs, Inc. over the last ten years is 6.11. The current 1.47 Current Ratio has changed 2.31% with respect to the historical average. Over the past ten years (40 quarters), PRPH's Current Ratio was at its highest in in the March 2018 quarter at 28.70. The Current Ratio was at its lowest in in the December 2016 quarter at 1.41.

ProPhase Labs, Inc. (PRPH) Current Ratio by Quarter and Year

Discovering the peaks and valleys of ProPhase Labs, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

ProPhase Labs, Inc. (PRPH) Average Current Ratio

How has PRPH Current Ratio performed in the past?

The current Current Ratio of ProPhase Labs, Inc. (PRPH) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

ProPhase Labs, Inc. (PRPH) Current Ratio vs. Peers

How is PRPH’s Current Ratio compared to its peers?

ProPhase Labs, Inc.’s Current Ratio is less than LumiraDx Limited (2.91), greater than Star Equity Holdings, Inc. (0), less than Enzo Biochem, Inc. (2.82), greater than Genetron Holdings Limited (0), less than Neuronetics, Inc. (3.16), greater than Intelligent Bio Solutions Inc. (1.14), less than Biodesix, Inc. (3.40), greater than Precipio, Inc. (0.73), less than DarioHealth Corp. (1.57), less than Olink Holding AB (publ) (5.60), less than Exagen Inc. (4.05), less than Sotera Health Company (2.88), less than Burning Rock Biotech Limited (3.11), less than Psychemedics Corporation (1.59), less than Sera Prognostics, Inc. (2.11),

Build a custom stock screener for ProPhase Labs, Inc. (PRPH) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like ProPhase Labs, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

ProPhase Labs, Inc. (PRPH) and other stocks custom spreadsheet templates

The easiest way to analyze a company like ProPhase Labs, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.